SCHEMBL5112364

SCHEMBL5112364

CCCc1c(Cc2ccnn2-c2ncccc2C#N)ncn2nc(C(F)F)nc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5108595 0.92 KDM4E (0.32) —
SCHEMBL5112468 0.88 — —
SCHEMBL5118207 0.88 PKM (0.33) —
SCHEMBL5119310 0.88 — —
SCHEMBL5110898 0.87 ALDH1A1 (0.33) —
SCHEMBL5113715 0.87 — —
SCHEMBL5114531 0.87 — —
SCHEMBL5118983 0.87 — —
SCHEMBL14289577 0.87 — —
SCHEMBL5118965 0.86 KDM4E (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080004269-A1 Pyrazolylmethy Heteroaryl Derivatives NEUROGEN CORPORATION 2008-01-03 — — US disclosed
US-20080004269-A1 Pyrazolylmethy Heteroaryl Derivatives NEUROGEN CORPORATION 2008-01-03 — — US disclosed
US-20080004269-A1 Pyrazolylmethy Heteroaryl Derivatives NEUROGEN CORPORATION 2008-01-03 — — US disclosed
EP-1807417-A2 PYRAZOLYLMETHYL HETEROARYL DERIVATIVES NEUROGEN CORPORATION (US) 2007-07-18 — — EP disclosed
WO-2006052546-A2 PYRAZOLYLMETHYL HETEROARYL DERIVATIVES NEUROGEN CORPORATION (US) 2006-05-18 — — WO disclosed
Send feedback